Projects per year
Fingerprint
Dive into the research topics where Jennifer Le-Rademacher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)
Odedina, F. F. T. (PI), Le-Rademacher, J. (CoPI), Shi, Q. Q. (CoPI), Freimuth, R. (CoPI), Odedina, F. (CoPI) & Liu, H. H. (CoPI)
9/16/22 → 8/31/26
Project: Research project
-
Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a secondary analysis of the phase III trial CALGB 50303
Morrison, V. A., Le-Rademacher, J., Bobek, O., Satele, D., Leonard, J. P. & Jatoi, A., Mar 2025, In: Journal of Geriatric Oncology. 16, 2, 102185.Research output: Contribution to journal › Article › peer-review
Open Access -
Breast cancer screening mammography among transgender and gender diverse (TGD) individuals: A nationwide study of >10, 000 TGD individuals.
Cathcart-Rake, E. J., Thao, V., Le-Rademacher, J., Helfinstine, D. A., Ruddy, K. J., Vachon, C., Davidge-Pitts, C., Carroll, E., Ridgeway, J., Shufelt, C., Amye, T. & Jatoi, A., Jun 2025, In: Journal of Clinical Oncology. 43, p. 1530 1 p.Research output: Contribution to journal › Review article › peer-review
-
Corrigendum to ‘Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial’: [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714] (Journal of Thrombosis and Haemostasis (2024) 22(6) (1704–1714), (S1538783624001697), (10.1016/j.jtha.2024.03.011))
EVE trial investigators, Feb 2025, In: Journal of Thrombosis and Haemostasis. 23, 2, p. 756 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Deficit accumulation frailty index and treatment tolerability in AML: data from CALGB 11001 and 11002 (Alliance)
Lai, C., Lee, M., Bobek, O., Le-Rademacher, J., Mandrekar, S., Roboz, G. J., Uy, G. L., Mandelblatt, J. S. & Klepin, H. D., Jan 28 2025, In: Blood Advances. 9, 2, p. 398-401 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The Impact of Design Misspecifications on Survival Outcomes in Cancer Clinical Trials
Ou, F. S., Zemla, T. & Le-Rademacher, J. G., Aug 2025, In: Cancers. 17, 16, 2609.Research output: Contribution to journal › Article › peer-review
Open Access